In conclusion, the findings presented in this paper demonstrated the cell-mediated anti-inflammatory activity of SAGE in the treatment of chronic inflammatory diseases such as periodontal disease, is mediated at least in part through TLR-2 and TLR-4 signaling pathway. Here, TLR2 is linked to periodontal disorder.